Affiliation:
1. Department of Medicinal Chemistry College of Pharmaceutical Sciences of Capital Medical University Beijing 100069 P. R. China
2. Beijing Area Major Laboratory of Peptide and Small Molecular Drugs Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China Beijing Laboratory of Biomedical Materials Laboratory for Clinical Medicine Capital Medical University Beijing 100069 P. R. China
3. Department of Core Facility Center Capital Medical University Beijing 100069 P. R. China
4. Beijing Institute of Hepatology Beijing Youan Hospital Capital Medical University Beijing 100069 P. R. China
5. Xuanwu Hospital Capital Medical University Beijing 100053 P. R. China
Abstract
AbstractSeveral DNA‐damaging antitumor agents, including ruthenium complexes, induce immunogenic cell death (ICD). In this study, an arginyl‐glycyl‐aspartic acid (RGD) peptide‐modified carboline ruthenium complex (KS‐Ru) is synthesized as a chemotherapeutic nanodrug and an ICD inducer. The RGD peptide, an integrin ligand, provides tumor‐specific targeting and promotes self‐assembly of the KS‐Ru complex. The pH‐responsive self‐assembly is assessed through transmission and scanning electron microscopy. Additionally, in vitro cytotoxic activity and anti‐metastasis ability are evaluated using MTT and Transwell assays, respectively, along with cellular immunofluorescence staining and imaging flow cytometry. The ability of the complex to inhibit primary tumor formation and lung metastasis in vivo is evaluated using Lewis lung cancer and A549 xenograft models. Furthermore, the tumor immune microenvironment is evaluated using single‐cell flow mass cytometry. KS‐Ru translocates to the nucleus, causing DNA damage and inducing ICD. Within the lysosomes, KS‐Ru self‐assembled into nanoflowers, leading to lysosomal swelling and apoptosis. Notably, the as‐synthesized pH‐dependent ruthenium nanomedicine achieves dual functionality—chemotherapy and immunotherapy. Moreover, the pH‐responsive self‐assembly of KS‐Ru enables simultaneous mechanisms in the lysosome and nucleus, thereby lowering the likelihood of drug resistance. This study provides valuable insight for the design of novel ruthenium‐based nanoantitumor drugs.
Funder
Beijing Municipal Commission of Education
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献